Coins
Top 100 Coins
Top 100 cryptocurrencies by market capitalizationTrending Cryptos
Trending Coins and TokensPerformance
Track market performance of cryptocurrenciesRecently Listed
Recently added cryptocurrencies in the last 30 daysGainers
The fastest-growing cryptos over the past 24 hoursAll Categories
Cryptocurrencies sorted by categoriesAll Time High
Cryptocurrencies that have recently reached their highest all time priceBlockchains
Analyze and compare key blockchain metricsGlobal Market Data
Global crypto charts: Market sentiment & flowEcosystems
Explore blockchain platforms: ecosystem projects, TVL, and other key metrics
Products
Research
Crypto market insights, reports, latest news, and mediaPrediction Markets
All-in-one analytics for prediction marketsHeatmaps
Cryptocurrency market state visualizationDrop Hunting
Potential airdrops and activitiesAlerts
Cryptocurrency signals and price alertsConverter
Cryptocurrency converterWidgets
Useful widgets for your siteFutures and Options
Analyze Bitcoin and Ethereum futures and options statisticsAffiliate Program
Join and earn by referring new subscribers!Rewards
Complete tasks and earn rewardsMarket Data API
Check out the details of our API plans/
Category Health & pharma
Eli Lilly bets on multi-dose Zepbound pen in GLP-1 retention push
Millions of people on GLP-1 weight-loss drugs know the weekly routine by heart: a new injector pen, a new box, another reminder to refill, and one ...
Feb, 23, 2026
2 min read
by Invezz
Merck creates separate oncology arm ahead of Keytruda patent loss
Merck said on Monday that it will split its human-health operations into two separate divisions, a move designed to sharpen focus across its portfo...
Feb, 23, 2026
3 min read
by Invezz
Novo stock drops 15% as obesity drug falls short in key trial
Shares of Novo Nordisk fell sharply after the company said its next-generation obesity drug CagriSema delivered weaker weight-loss results than a r...
Feb, 23, 2026
3 min read
by Invezz
Danaher stock: 3 ways Masimo deal could boost stock
Masimo (NASDAQ: MASI) pushed meaningfully higher on Feb. 17 after healthcare giant Danaher (NYSE: DHR) said it will acquire the pulse oximetry lead...
Feb, 18, 2026
by Invezz
CVS Health beats expectations as turnaround strategy gains traction
CVS Health delivered a stronger-than-expected fourth quarter, beating Wall Street estimates on both earnings and revenue as the company presses ahe...
Feb, 10, 2026
3 min read
by Invezz